Govindaraghavan Suresh, Sucher Nikolaus J
Network Nutrition - IMCD Australia, Bella Vista, NSW, Australia.
Science Department, Roxbury Community College, MA, USA.
Epilepsy Behav. 2015 Nov;52(Pt B):363-71. doi: 10.1016/j.yebeh.2015.03.004. Epub 2015 Apr 18.
Ingredients of commercial herbal medicines are assessed for quality primarily to ensure their safety. However, as complex mixtures of different groups of plant secondary metabolites, retention of overall phytochemical consistency of herbal medicines is pivotal to their efficacy. Authenticity and homogeneity of the herbs and strict regimes of physical processing and extract manufacturing are critical factors to maintain phytochemical consistency in commercial products. To ensure both safety and efficacy of herbal medicines, implementation of and adherence to good agricultural and collection practice (GACP), good plant authentication and identification practice (GPAIP), good manufacturing practice (GMP) before and during the manufacturing process, and good laboratory practice (GLP) in analysis are necessary. Establishment and application of harmonized multilaboratory-validated analytical methods and transparency in the supply (value) chain through vendor audits are additional requirements in quality assurance. In this article, we outline steps of a comprehensive quality assurance paradigm aimed at achieving and maintaining safety, consistent phytochemical composition, and clinical efficacy of ingredients of herbal medicines. This article is part of a Special Issue entitled Botanicals for Epilepsy.
对商业草药的成分进行质量评估主要是为了确保其安全性。然而,作为不同组植物次生代谢产物的复杂混合物,保持草药整体植物化学一致性对其疗效至关重要。草药的真实性和同质性以及严格的物理加工和提取物制造流程是维持商业产品中植物化学一致性的关键因素。为确保草药的安全性和有效性,在制造过程之前和期间实施并遵守良好农业和采集规范(GACP)、良好植物鉴定和识别规范(GPAIP)、良好生产规范(GMP)以及在分析中遵守良好实验室规范(GLP)是必要的。建立并应用经过多实验室验证的统一分析方法以及通过供应商审计确保供应链(价值链)的透明度是质量保证的额外要求。在本文中,我们概述了一个全面质量保证范式的步骤,旨在实现并维持草药成分的安全性、一致的植物化学组成和临床疗效。本文是名为“用于癫痫的植物药”的特刊的一部分。